Your browser doesn't support javascript.
loading
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma.
Menevse, Ayse N; Ammer, Laura-Marie; Vollmann-Zwerenz, Arabel; Kupczyk, Marcell; Lorenz, Julia; Weidner, Lorraine; Hussein, Abir; Sax, Julian; Mühlbauer, Jasmin; Heuschneider, Nicole; Rohrmus, Celine; Mai, Laura S; Jachnik, Birgit; Stamova, Slava; Volpin, Valentina; Durst, Franziska C; Sorrentino, Antonio; Xydia, Maria; Milenkovic, Vladimir M; Bader, Stefanie; Braun, Frank K; Wetzel, Christian; Albert, Nathalie L; Tonn, Joerg-Christian; Bartenstein, Peter; Proescholdt, Martin; Schmidt, Nils O; Linker, Ralf A; Riemenschneider, Markus J; Beckhove, Philipp; Hau, Peter.
Afiliación
  • Menevse AN; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Ammer LM; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Vollmann-Zwerenz A; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Kupczyk M; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Lorenz J; Department of Neuropathology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Weidner L; Department of Neuropathology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Hussein A; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Sax J; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Mühlbauer J; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Heuschneider N; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Rohrmus C; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Mai LS; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Jachnik B; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Stamova S; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Volpin V; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Durst FC; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Sorrentino A; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Xydia M; Division of Interventional Immunology, Leibniz Institute for Immunotherapy (LIT), 93053, Regensburg, Germany.
  • Milenkovic VM; Department of Psychiatry and Psychotherapy, University of Regensburg, Molecular Neurosciences, 93053, Regensburg, Germany.
  • Bader S; Department of Psychiatry and Psychotherapy, University of Regensburg, Molecular Neurosciences, 93053, Regensburg, Germany.
  • Braun FK; Department of Neuropathology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Wetzel C; Department of Psychiatry and Psychotherapy, University of Regensburg, Molecular Neurosciences, 93053, Regensburg, Germany.
  • Albert NL; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 80336, Munich, Germany.
  • Tonn JC; Department of Neurosurgery, University Hospital of Munich, LMU Munich, 80336, Munich, Germany.
  • Bartenstein P; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 80336, Munich, Germany.
  • Proescholdt M; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Schmidt NO; Department of Neurosurgery, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Linker RA; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Riemenschneider MJ; Department of Neurosurgery, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Beckhove P; Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Hau P; Department of Neuropathology, University Hospital Regensburg, 93053, Regensburg, Germany.
Acta Neuropathol Commun ; 11(1): 75, 2023 05 08.
Article en En | MEDLINE | ID: mdl-37158962
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Acta Neuropathol Commun Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Acta Neuropathol Commun Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido